-
OligoWorks SPE Kits: Boosting Oligonucleotide Bioanalysis Efficiency
New OligoWorks Solid Phase Extraction (SPE) Kits for extraction and bioanalysis of oligonucleotides deliver advantages over liquid-liquid extraction (LLE) and other existing SPE kits and sample preparation methods. Read on to discover how.
Recent Posts
Uncovering the Why of Breast Cancer with LC/MS solutions
Chances are that you or someone you know has been directly impacted by breast cancer. With 2,088,849 new cases and 626,679 deaths globally,1 it is the most frequently diagnosed cancer in women in most countries (154 of 185) and is the leading cause of cancer death in women in over 100 countries. Fortunately, significant strides...
A Relentless Approach to Delivering Benefit to Customers in Everything We Do
At Waters there is a fundamental ethic in the company around doing the right thing to help customers, fellow employees and the world by advancing science to enhance human health and well-being. Everything we do traces to this purpose and is based on a singular imperative to “deliver benefit”, given to us by our founder...
Bring efficiency back to your lab: How aging technology hinders ideal performance
In this series, we review considerations for keeping your lab at the forefront of science. As we adjust to living and working in a pandemic and anticipate future global and geopolitical events, Waters remains dedicated to supporting your business and unlocking the potential of your science. Our holistic separations solutions and expert support help you...
Addressing the Mystery of Sample Loss
Many years ago, I was hired by a biopharma company to develop analytical methods for therapeutic oligonucleotides. When a new colleague warned me about sample loss on LC columns I looked at him with skepticism. “Yes,” he insisted, “part of your DNA sample may be irreversibly bound to the column and you will never see...
Mutagenic Impurity Risk Assessment Throughout the Development and Manufacturing Process
Since the early 2000s and the advent of the first guidance relating to mutagenic impurities developed by the European Medicines Agency (EMA), it has been necessary to assess the risk posed by mutagenic impurities. Although initially it was thought that avoidance was an option, it quickly became apparent that this was not a viable strategy. ...
Five Questions with Waters’ New President and CEO, Udit Batra
On September 1, 2020, Udit Batra became Waters’ President and CEO. Udit brings a wealth of knowledge and experience to Waters, having previously held executive positions at Novartis and Merck KGaA. Most recently, he served as the CEO of MilliporeSigma, the life science tools business at Merck KGaA. We caught up with Udit during this...
Popular Topics
ACQUITY QDa (17) bioanalysis (11) biologics (14) biopharma (26) biopharmaceutical (36) biotherapeutics (17) case study (17) chromatography (14) data integrity (22) food analysis (12) HPLC (15) LC-MS (22) liquid chromatography (LC) (20) mass detection (16) mass spectrometry (MS) (54) method development (13) STEM (12) sustainability (12)